Table 1 shows the characteristics of all 20 studies.[27–46] These studies mainly assessed the association between the mRNA expression of SIX1, SIX2, SIX3, SIX4, SIX5, and SIX6 with clinical parameters of breast cancer. This evidence concerns the gene SIX5 and breast cancer.